U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06283420) titled 'Metabolic Response to Iniciation of Heart Failure Therapy' on Feb. 21.
Brief Summary: This protocol is part of the CarDia project - National Institute for Metabolic and Cardiovascular Disease Research (EXCELES Program, ID: LX22NPO5104), funded by the European Union - Next Generation EU. The protocol is part of Work Package 5 (WP5): metabolic disorders in heart failure.
The goal of this observational protocol is to monitor the biochemical and metabolomic response to the initiation of therapy for heart failure with standard drugs (SGLT2i, sGC stimulators, ARNI) and whether this early response (within first 3 months) predicts the furt...